FAQs and Guidances

Federal government:

NCI source book and resources: clinical and laboratory operations
NCI Emergency Resources: What people with cancer should know about the coronavirus
NCI guidance: Interim guidance for patients on clinical trials supported by the NCI Cancer Therapy Evaluation Program (CTEP) and the NCI Community Oncology Research Program (NCORP).
CTEP coronavirus guidance
COVID-19 scientific interest group
FDA guidance: Conduct of clinical trials of medical products during COVID-19 pandemic
FDA guidance update: Blood donations
- More FDA updates: Medical Countermeasures Initiative, on COVID-19
- FDA continues to facilitate access to crucial medical products, Including ventilators
- FDA provides update on patient access to certain REMS drugs during COVID-19 public health emergency
- A message to patients with cancer and Health Care Providers About COVID-19
- Update: Diagnostic testing for COVID-19

Professional societies:

American Society of Clinical Oncology FAQ: Emerging issues and challenges in caring for patients with cancer during the coronavirus pandemic
American Cancer Society FAQ: Common questions about the new coronavirus outbreak
- ACS clinical guidance: COVID-19 elective case triage guidelines for surgical care
- Create a surgical review committee for COVID-19-related surgical triage decision making
- COVID-19 and 2020 ACS Grants
Society for Immunotherapy of Cancer Resources: Patient management and basic and translational research
Community Oncology Alliance resources: Coronavirus (COVID-19) practice resources and protocols
Leukemia & Lymphoma Society FAQ: Resources and what you should know about the coronavirus
American Society for Radiation Oncology FAQ: COVID-19 recommendations and information
American College of Surgeons resources: For the surgical community
Society for Immunotherapy of Cancer resources: Implications for patients, translational research
American Society for Transplantation and Cellular Therapy resources
European Blood and Marrow Transplantation Society recommendations
World Marrow Donor Association resources

Research centers:

St. Jude Children’s Research Hospital FAQ: COVID-19 and children with cancer
Journal of the National Comprehensive Cancer Network: How to manage cancer care during COVID-19 pandemic

DOWNLOAD THE PDF

Table of Contents

YOU MAY BE INTERESTED IN

Clinical

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Three years ago, researchers from Memorial Sloan Kettering Cancer Center published stunning results: For the 5% of rectal cancer patients whose tumors are mismatch-repair deficient, neoadjuvant dostarlimab-gxly (Jemperli) has the makings of a silver bullet.

May 02, 2025

Vol.51 No.17

By Jacquelyn Cobb

Clinical

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertile
Six years later, she is well—and pregnant with her third child

When Kelly Spill was eight months pregnant, she experienced some constipation and noticed blood in her stool. Her OBGYN wasn’t worried.

The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document

An updated version of President Trump’s budget request published on May 2 comes as a disappointment for those who hoped that the White House would rethink the draconian cuts contained in an earlier, confidential version of the document that ended up being leaked to the press.

May 02, 2025

Vol.51 No.17

By Jacquelyn Cobb and Claire Marie Porter

News Analysis

NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science

After nearly three decades of reviewing NCI-funded extramural projects and sometimes saving NCI from its own folly, the Board of Scientific Advisors has been terminated as part of the Trump administration’s drive to reduce the size of the federal government.

NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing

In the starkest opposition yet by Republicans to the Trump administration’s attacks on HHS agencies, senators from both parties sounded an alarm about the damage being done to biomedical research in the U.S.

May 02, 2025

Vol.51 No.17

By Claire Marie Porter

Bertagnolli: NIH funding cuts are “unprecedented and harmful”
AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

“We stand at the edge of discovery, and on the brink of losing it,” said Patricia M. LoRusso, the 2024-2025 president of the American Association for Cancer Research. “I believe this is the most scientifically promising moment in the history of cancer research.”

May 02, 2025

Vol.51 No.17

By Claire Marie Porter

FAQs and Guidances

YOU MAY BE INTERESTED IN

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertile
Six years later, she is well—and pregnant with her third child

The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document

NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science

NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing

Bertagnolli: NIH funding cuts are “unprecedented and harmful”
AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

Renew today!

Subscriber content

Never miss an issue!

Login

FAQs and Guidances

YOU MAY BE INTERESTED IN

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertileSix years later, she is well—and pregnant with her third child

The White House “skinny budget” document cuts NIH by nearly 40%The cuts are consistent with the previously leaked “passback” document

NIH eliminates the NCI Board of Scientific AdvisorsOver its 28 year history, BSA shaped NCI-funded extramural science

NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”Cancer research also took center stage at Senate appropriations hearing

Bertagnolli: NIH funding cuts are “unprecedented and harmful”AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

Never miss an issue!

Login

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertile
Six years later, she is well—and pregnant with her third child

The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document

NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science

NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing

Bertagnolli: NIH funding cuts are “unprecedented and harmful”
AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”